ArticleIntensive care medicine experimental2026
Digital performance testing reveals how redesigned return cannulas can enhance VV-ECMO performance.
Article in Intensive care medicine experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundVeno-venous extracorporeal membrane oxygenation (VV-ECMO) provides life support for patients with severe respiratory failure by oxygenating blood when the lungs are impaired. Standard VV-ECMO uses two cannulas to drain and return blood. However, recirculation, where oxygenated blood is immediately withdrawn back into the circuit by the drainage cannula, reduces effective oxygen delivery. With survival rates around 62%, optimizing VV-ECMO is essential to improve patient outcomes.
methodsIn this study, computational modeling was used to investigate recirculation, oxygen delivery, and the risk of thrombosis and hemolysis for six different return cannula designs under three ECMO flow rates (2, 4, and 6 L/min). Two commercially available and four novel cannulas were tested to evaluate whether design modifications could improve oxygen delivery. Among the novel designs, one was open with additional holes, while the others featured closed or perforated caps.
resultsAt low ECMO flow (2 L/min), all cannulas showed similar oxygen saturation (78%) and low recirculation (1.6%), indicating minimal impact of cannula design on VV-ECMO performance. At high flow (6 L/min), closed-tip cannulas reduced recirculation by 40-50% and increased oxygen saturation by 6%, without substantially affecting the risk of thrombosis and hemolysis. Moreover, the partial pressure of oxygen increased by up to 151% compared to the cannula commonly used in clinical practice.
conclusionOur findings suggest that new return cannula design could enhance VV-ECMO performance, especially in patients relying predominantly on the support due to severely impaired lung function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.